VERACYTE, INC. — Director's Dealing 2020

Aug 5, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VERACYTE, INC. (VCYT)
CIK: 0001384101
Period of Report: 2020-07-31

Reporting Person: Kennedy Giulia C (Chief Scientific & Med Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-07-31	Common Stock	M	20000	$20.21	Acquired	100487	Direct
2020-07-31	Common Stock	S	20000	$35.3347	Disposed	80487	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-07-31	Stock Option (right to buy)	$20.21	M	20000	Disposed	2029-02-27	Common Stock (20000)	Direct

Footnotes

F1: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020.

F2: Represents weighted average sales price. Sale prices for the transactions range from $35.21 to $35.78. Detailed information regarding the number of shares sold at each separate price will be provided to the
SEC, the issuer or a shareholder upon request.

F3: The option becomes exercisable as to 25% of the shares on February 28, 2020, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous
service thereafter.